CFHR5 and myeloid sarcoma: This observation hints at a possible role of CFHR5 in MS pathophysiology, given its involvement in other autoimmune diseases where both complement system deficiencies and overactivation contribute to disease development and progression (44), such as systemic lupus erythematosus (SLE) (45).